Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Johnson & Johnson turns Paige to $100m
Johnson & Johnson Innovation – JJDC has co-led the computational pathology technology provider's series C round to take its total funding to $195m.
Atalanta attains series A
Atalanta Therapeutics has launched out of UMass with $110m in combined series A and partnership funding to develop therapies for neurodegenerative diseases.
Investors hook up Hinge Health with $300m
IP Group portfolio company Hinge Health has pushed its valuation to $3bn following a $300m series D round co-led by Coatue Management and Tiger Global.
Flexiv assembles $100m series B
Investors have thrown their backing behind a round topping $100m for Stanford-linked production automation robot developer Flexiv.
Graphcore grafts on $222m
The intelligent chipmaker, which traces its roots back to University of Bristol, has secured series E funding at a $2.77bn valuation.
Neomorph bonds $109m
Based on inventions from Harvard and Dana-Farber Cancer Institute, Neomorph was launched earlier this year with the support of Deerfield Management.
Singlera detects $150m in series B cash
Fudan University’s Furong Investment has co-led a round for Singlera Genomics, which will use the cash to advance its pipeline of cancer screening products.
Monzo magnifies series G to $167m
The challenger bank’s Vanderbilt University-backed series G has been boosted by new funding at the same $1.57bn valuation.

Other News

Chang Guang charts $375m course
The CAS Star-backed round looks set to be the last for the satellite imaging technology producer before a planned initial public offering.
Menlo Security locks down $100m
The anti-malware software provider's series E round has valued the UC Berkeley spinout at $800m.
Whoop straps on $100m
The fitness and sleep tracker provider, an alumnus of Harvard Innovation Lab, was valued at $1.2bn in a round that took its total funding past $200m.
AavantiBio activates with $107m
Sarepta Therapeutics provided $15m in a series A round for the company, which is advancing University of Florida research.
Oxford Nanopore presses $108m
Oxford Nanopore has continued its funding streak with another $108m, bringing this year's haul to more than $208m and its overall total to around $800m.
Beyond Limits lines up $133m series C
Group 42 and BP Ventures have co-led a series C round for Caltech and Nasa spinout Beyond Limits, with $113m already closed.

Editor's Picks

Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Immunocore smashes European biotech records
Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.
test reg